Compound Summary
Isovitexin
Compound Information
Isovitexin
Compound Name: | Isovitexin |
Compound CID: | 162350 |
Synonyms: | Isovitexin 38953-85-4 Saponaretin Homovitexin 29702-25-8 More... |
Iupac Name: | 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one |
InChI: | InChI=1S/C21H20O10/c22-7-14-17(26)19(28)20(29)21(31-14)16-11(25)6-13-15(18(16)27)10(24)5-12(30-13)8-1-3-9(23)4-2-8/h1-6,14,17,19-23,25-29H,7H2/t14-,17-,19+,20-,21+/m1/s1 |
InChIKey: | MYXNWGACZJSMBT-VJXVFPJBSA-N |
Canonical Smiles: | C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)C4C(C(C(C(O4)CO)O)O)O)O)O |
Isomeric Smiles: | C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O |
Molecular Weight: | 432.4 |
Molecular Formula: | C21H20O10 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Isovitexin
Molecular Weight: | 432.4 |
Molecular Formula: | C21H20O10 |
Hydrogen Bond Donor Count: | 7 |
Hydrogen Bond Acceptor Count: | 10 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 31 |
Complexity: | 690 |
Synonyms
Isovitexin
| Isovitexin | Isovitexin |
|---|---|
Isovitexin |
38953-85-4 |
Saponaretin |
Homovitexin |
29702-25-8 |
6-Glucosylapigenin |
Apigenin-6-C-glucoside |
Isoavroside |
6-C-Glucosylapigenin |
Avroside |
Apigenin 6-C-glucoside |
ISOVITEXIN WITH |
CHEBI:18330 |
KTQ9R9MS0Q |
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-ylchromen-4-one |
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-4H-chromen-4-one |
4H-1-Benzopyran-4-one, 6-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)- |
(1S)-1,5-anhydro-1-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-6-yl-D-glucitol |
4H-1-Benzopyran-4-one, 6-.beta.-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)- |
SMR001215816 |
UNII-KTQ9R9MS0Q |
CCRIS 9341 |
beta-D-isovitexin |
Apigenin 6-C-beta-glucopyranoside |
Isovitexin with HPLC |
Saponaretin; Homovitexin |
C01714 |
ISOVITEXIN WHO-DD |
MLS000563041 |
MLS002473147 |
SCHEMBL513620 |
Isovitexin, analytical standard |
CHEMBL465360 |
Flavone, 6-beta-D-glucopyranosyl-4,5,7-trihydroxy- |
DTXSID60952152 |
6-C-beta-D-Glucopyranosylapigenin |
HMS2268O04 |
HMS3886D14 |
HY-N0773 |
Isovitexin, >=98.0% (HPLC) |
ZINC4095704 |
BDBM50486938 |
MFCD00076044 |
s9035 |
AKOS032948364 |
CCG-208397 |
6-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
NCGC00163578-01 |
AC-34970 |
AS-56231 |
6-C-.BETA.-D-GLUCOPYRANOSYLAPIGENIN |
CS-0009796 |
Isovitexin 100 microg/mL in Acetonitrile:Methanol |
Isovitexin, primary pharmaceutical reference standard |
Q3155636 |
Flavone, 6-.beta.-D-glucopyranosyl-4,5,7-trihydroxy- |
Ethyl6-amino-5-cyano-2-methyl-4-phenyl-4H-pyran-3-carboxylate |
4H-1-Benzopyran-4-one, 6-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)- (VAN) |
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-ylchromen-4-one |
Experimental Data
Isovitexin
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 100.000000000000000 | umol/L | 17.300000000000000 | 19.000000000000000 | 9.830000000000000 | 24.700000000000000 | 26.400000000000000 | 0.070000000000000 | S | N2 | 35413150 | Active | |
| Caenorhabditis elegans | 50.000000000000000 | umol/L | 17.300000000000000 | 18.700000000000000 | 8.090000000000000 | 24.700000000000000 | 27.900000000000000 | 0.130000000000000 | S | N2 | 35413150 | Active |
Experimental Data Visualization
Isovitexin
Statistics Data
Isovitexin
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 9.830000000000000 | 0.130000000000000 | 1 | 2 |
Statistics Data Visualization
Isovitexin
